The estimated Net Worth of Robert A. Michael is at least $48.1 Milion dollars as of 28 February 2024. Mr. Michael owns over 68,879 units of Abbvie Inc stock worth over $19,195,331 and over the last 8 years he sold ABBV stock worth over $20,100,776. In addition, he makes $8,772,850 as Chief Financial Officer a Senior Vice President at Abbvie Inc.
Sign up
Mr. Michael ABBV stock SEC Form 4 insiders trading
Robert has made over 6 trades of the Abbvie Inc stock since 2017, according to the Form 4 filled with the SEC. Most recently he sold 68,879 units of ABBV stock worth $12,153,700 on 28 February 2024.
The largest trade he's ever made was selling 68,879 units of Abbvie Inc stock on 28 February 2024 worth over $12,153,700. On average, Robert trades about 7,594 units every 150 days since 2017. As of 28 February 2024 he still owns at least 98,645 units of Abbvie Inc stock.
You can see the complete history of Mr. Michael stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Robert Michael biography
Robert A. Michael serves as Chief Financial Officer, Senior Vice President of the Company. Mr. Michael has been AbbVie’s Vice President, Controller, since March 1, 2017 and served as AbbVie’s Vice President, Treasurer from 2015 to 2016, and as Vice President, Controller, Commercial Operations from 2013 to 2015. He joined Abbott Laboratories in 1993 and held numerous positions in the finance organization.
What is the salary of Robert Michael?
As the Chief Financial Officer a Senior Vice President of Abbvie Inc, the total compensation of Robert Michael at Abbvie Inc is $8,772,850. There are 4 executives at Abbvie Inc getting paid more, with Richard Gonzalez having the highest compensation of $21,610,600.
How old is Robert Michael?
Robert Michael is 49, he's been the Chief Financial Officer a Senior Vice President of Abbvie Inc since 2018. There are 29 older and 3 younger executives at Abbvie Inc. The oldest executive at Abbvie Inc is Edward Liddy, 73, who is the Independent Director.
What's Robert Michael's mailing address?
Robert's mailing address filed with the SEC is North Waukegan Road, North Chicago, Lake County, Illinois, 60044, United States.
Insiders trading at Abbvie Inc
Over the last 12 years, insiders at Abbvie Inc have traded over $324,915,370 worth of Abbvie Inc stock and bought 214,015 units worth $14,446,494 . The most active insiders traders include Richard A Gonzalez, Frederick H Waddell a Glenn F Tilton. On average, Abbvie Inc executives and independent directors trade stock every 22 days with the average trade being worth of $7,529,855. The most recent stock trade was executed by Richard A Gonzalez on 5 August 2024, trading 66,500 units of ABBV stock currently worth $12,403,580.
What does Abbvie Inc do?
AbbVie Inc. is a pharmaceutical company headquartered in North Chicago, Illinois. It is ranked 6th on the list of largest biomedical companies by revenue. Their primary product is Humira (adalimumab) ($21 billion in 2022 revenues, 37% of total), administered via injection. It is approved to treat autoimmune diseases including rheumatoid arthritis, Crohns disease, plaque psoriasis, and ulcerative colitis.
What does Abbvie Inc's logo look like?
Complete history of Mr. Michael stock trades at Abbvie Inc
Abbvie Inc executives and stock owners
Abbvie Inc executives and other stock owners filed with the SEC include:
-
Richard Gonzalez,
Chairman of the Board, Chief Executive Officer -
Laura Schumacher,
Vice Chairman, External Affairs and Chief Legal Officer -
Carlos Alban,
Vice Chairman, Chief Commercial Officer -
Michael Severino,
President, Vice Chairman -
Robert Michael,
Chief Financial Officer, Senior Vice President -
William Chase,
Executive Vice President - Finance and Administration -
Richard A. Gonzalez,
Chairman & CEO -
Dr. Michael E. Severino,
Vice Chairman & Pres -
Laura J. Schumacher,
Vice Chairman of External Affairs, Chief Legal Officer & Corp. Sec. -
Timothy Richmond,
Chief Human Resource Officer, Executive Vice President -
Robert A. Michael,
Vice Chairman of Fin. & Commercial Operations and CFO -
Glenn Tilton,
Lead Independent Director -
Robert Alpern,
Independent Director -
Edward Rapp,
Independent Director -
Brett Hart,
Independent Director -
William Burnside,
Independent Director -
Roxanne Austin,
Independent Director -
Frederick Waddell,
Independent Director -
Melody Meyer,
Independent Director -
Edward Liddy,
Independent Director -
Thomas Freyman,
Independent Director -
Rebecca Roberts,
Independent Director -
Brian Durkin,
Vice President, Controller -
Jeffrey Stewart,
Senior Vice President, U.S. Commercial Operations -
Nicholas Donoghoe,
Senior Vice President - Enterprise Innovation -
Azita Saleki-Gerhardt,
Executive Vice President - Operations -
Henry Gosebruch,
Executive Vice President, Chief Strategy Officer -
Scott T. Reents,
Sr. VP & CFO -
Jeffrey Ryan Stewart,
Exec. VP & Chief Commercial Officer -
Henry O. Gosebruch,
Exec. VP & Chief Strategy Officer -
Scott C. Brun M.D.,
VP of Scientific Affairs & Head of AbbVie Ventures -
Timothy J. Richmond,
Exec. VP & Chief HR Officer -
Elizabeth Shea,
VP of Investor Relations -
Dr. Thomas J. Hudson,
Sr. VP of R&D and Chief Scientific Officer -
Dr. Azita Saleki-Gerhardt,
Exec. VP of Operations -
Thomas A. Hurwich,
VP, Controller -
Jennifer L. Davis,
-
Roy S Roberts,
Director -
Laboratories Abbott,
10% owner -
John M Leonard,
SVP, Chief Scientific Officer -
Elaine K. Sorg,
SVP, US COMMERCIAL OPERATIONS -
Perry C Siatis,
EVP, GC AND SECRETARY -
Carrie C Strom,
SVP & PRES GLOBAL ALLERG AESTH -
Thomas J Hudson,
SVP, CSO, GLOBAL RESEARCH -
Scott T Reents,
EVP, CHIEF FINANCIAL OFFICER -
Susan E Quaggin,
-
Kevin K Buckbee,
SVP, CONTROLLER -
Roopal Thakkar,
SVP, CMO, GLOBAL THERAPEUTICS